Dysregulation of miR-125b predicts poor response to therapy in pediatric acute lymphoblastic leukemia.

Nashwa El-KhazragyAmal Ali ElshimySafaa Shawky HassanSafa MatboulyGehan SafwatMohamed ZannounRamez A Riad

Published in: Journal of cellular biochemistry (2018)

miR-125b and Bcl-2 together are potent predictors for the prognosis and, therefore, can be used as therapeutic targets in childhood ALL.

Keyphrases